Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
80 participants
INTERVENTIONAL
2011-02-28
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Printing Guides in Total Knee Arthroplasty
NCT04206202
Implementation of Indication Criteria for Total Knee Replacement in Osteoarthritis (Value-based TKR)
NCT04837053
TOKA: Custom Made Devices for High Tibial Osteotomy (HTO) - Clinical Investigation
NCT04574570
TKA Using Patient-Specific Instrumentation
NCT03117959
Total Knee Arthroplasty Guidance Systems Study
NCT02830997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Register
Register
Custom guides
Symbios custom guides for TKA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Custom guides
Symbios custom guides for TKA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed signed consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brigitte Jolles, MD
Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHUV - Site HO
Lausanne, CH, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HO 278/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.